OncoSec Medical Correlations

ONCSDelisted Stock  USD 0.06  0  3.63%   
The current 90-days correlation between OncoSec Medical and ZyVersa Therapeutics is 0.06 (i.e., Significant diversification). The correlation of OncoSec Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

OncoSec Medical Correlation With Market

Good diversification

The correlation between OncoSec Medical and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding OncoSec Medical and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Moving together with OncoSec Stock

  0.84BKRKF PT Bank RakyatPairCorr
  0.9BKRKY Bank RakyatPairCorr
  0.87TLK Telkom Indonesia TbkPairCorr
  0.86PPERF Bank Mandiri PerseroPairCorr
  0.85PPERY Bank Mandiri PerseroPairCorr
  0.95MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.74BA Boeing Fiscal Year End 29th of January 2025 PairCorr

Moving against OncoSec Stock

  0.93CSCO Cisco Systems Aggressive PushPairCorr
  0.92AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.9PTAIF PT Astra InternationalPairCorr
  0.86T ATT Inc Fiscal Year End 22nd of January 2025 PairCorr
  0.85SSNLF Samsung ElectronicsPairCorr
  0.85AXP American Express Fiscal Year End 24th of January 2025 PairCorr
  0.85CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.83WMT Walmart Aggressive PushPairCorr
  0.77CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr
  0.74HPQ HP IncPairCorr
  0.73HD Home DepotPairCorr
  0.59XOM Exxon Mobil Corp Sell-off TrendPairCorr
  0.35TLKMF Telkom Indonesia TbkPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PALIZVSA
FWBIZVSA
NAVBIMMX
FWBIPALI
FWBINAVB
PHIOPALI
  
High negative correlations   
UNCYZVSA
UNCYPALI
FWBIUNCY
NAVBUNCY
PHIOAPGN
FWBIATNF

Risk-Adjusted Indicators

There is a big difference between OncoSec Stock performing well and OncoSec Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OncoSec Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

View OncoSec Medical Related Equities

 Risk & Return  Correlation

OncoSec Medical Corporate Management

Robert CPAVP ControllerProfile
Kim JaffeAssistant OperationsProfile
Robert ArchCEO PresProfile
Tu MScVP OperationsProfile
CPA CFAExec CFOProfile
Mai MDConsultantProfile
Sandra AungSr OfficerProfile

Still Interested in OncoSec Medical?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.